Commercial & evidence strategy for market access success
Disruptive Health Tech & integrated care
Digital Medicine & Healthcare AI
Microbiome products
Innovative biotech
Value Creation
Value is being created by making appropriate scientific and commercial choices right from the start of the development programme.
Start shaping product value by including your commercial goals.
Value to Price
In the era of value-based pricing, Health Technology Assessment and growing healthcare budget pressure, your key to commercial success lies in value demonstration.
Generate evidence that supports reimbursement and patient access.
Talking Value
Fact : people are not good at communicating scientific concepts, data or complex ideas.
Share your vision, commercial and access plan for partner & investor confidence.
Value in 2023 – The dynamics to anticipate in the commercial and market access environment
What is value in 2023? What are the major dynamics you want to consider as you craft your asset and commercial strategy, as well as your development programme? What are the appropriate actions to take in 2023 to convince partners and investors, and to shape an asset that shows broad value to all stakeholders?
What is a value creation strategy?
Apersy’s expertise and approach to market access is all about value and value creation. But what exactly is this illusive concept of value? And how and why do you leverage value to achieve optimal pricing, speedy reimbursement and patient access?
We build on our longstanding experience in Health Economics, strategic pricing & reimbursement, investor due diligence & portfolio advisory to provide a holistic picture of commercial and access activities
How Apersy
support you
Value, access & pricing projects
Expert opinion and on-demand support
Market Access function support
Training and Mentoring
Get in touch
To hear more about Apersy’s expertise and working approach, for queries, projects and collaborations.
